MarketScreener Strategies Daiichi Sankyo Company, Limited

Equities

Market Closed - Japan Exchange Other stock markets 07:30:00 14/07/2025 BST			5-day change	1st Jan Change
3,338.00 ^JPY	+2.46%		+3.57%	-23.30%

07-09	Turalio Final Long-Term Data Showed Sustained Clinical Benefit in Patients with Tenosynovial Giant Cell Tumor from Open-Label Extension of Enliven Phase 3 Trial	CI
07-01	Tranche Update on Daiichi Sankyo Company, Limited's Equity Buyback Plan announced on April 25, 2025.	CI

December 31, 2024 at 12:23 pm

No results for this search

Daiichi Sankyo: Voluntary withdrawal of MAA in the EU for Dato-DXd

December 31, 2024 at 12:23 pm

Daiichi Sankyo: Will Boost ADC Cancer Drug Production